Nov 16, 2023 8:15am EST Ensysce Biosciences Announces Enrollment Completion for PF614-201 Clinical Study
Oct 18, 2023 8:15am EDT Ensysce Biosciences Announces Poster Presentation at the AAPS 2023 PharmSci 360
Oct 11, 2023 8:15am EDT Ensysce Biosciences Chief Medical Officer to Chair the 17th Annual Pain Therapeutics Summit
Sep 26, 2023 8:15am EDT Ensysce Biosciences Announces Completion of Site Initiation Visit for PF614-201 Clinical Study
Sep 19, 2023 8:15am EDT Ensysce Biosciences to Host Research and Development FAQ Session Following PAINWeek Symposium on September 21, 2023
Sep 14, 2023 8:15am EDT Ensysce Biosciences Completes Scale Up Manufacture of PF614 to Support Phase 3 Studies